Middle East Healthcare Company (TADAWUL:4009)
Saudi Arabia
· Delayed Price · Currency is SAR 60.40
+0.90 (1.51%)
May 29, 2025, 3:18 PM AST
TADAWUL:4009 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 2,927 | 2,883 | 2,653 | 2,152 | 1,873 | 1,751 | Upgrade
|
| Revenue Growth (YoY) | 8.24% | 8.66% | 23.30% | 14.90% | 6.97% | 16.97% | Upgrade
|
| Cost of Revenue | 1,802 | 1,781 | 1,649 | 1,480 | 1,277 | 1,189 | Upgrade
|
| Gross Profit | 1,126 | 1,102 | 1,004 | 671.99 | 595.14 | 561.78 | Upgrade
|
| Selling, General & Admin | 700.99 | 661.1 | 679.76 | 531.65 | 540.9 | 454.37 | Upgrade
|
| Operating Expenses | 700.99 | 661.1 | 679.76 | 531.65 | 540.9 | 454.37 | Upgrade
|
| Operating Income | 424.84 | 440.93 | 323.97 | 140.34 | 54.24 | 107.41 | Upgrade
|
| Interest Expense | -207.67 | -220.59 | -153.18 | -69.01 | -41.52 | -31.11 | Upgrade
|
| Other Non Operating Income (Expenses) | 31.96 | 25.83 | 20.9 | 11.87 | 8.19 | 6.06 | Upgrade
|
| EBT Excluding Unusual Items | 248.92 | 246.17 | 191.69 | 83.2 | 20.91 | 82.35 | Upgrade
|
| Merger & Restructuring Charges | 45.45 | 45.45 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.52 | -0.52 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 133.03 | 19.06 | -0.76 | -1.98 | -1.68 | -1.67 | Upgrade
|
| Pretax Income | 426.89 | 310.16 | 190.94 | 81.22 | 19.23 | 80.69 | Upgrade
|
| Income Tax Expense | 24.32 | 26.28 | 170.44 | 9.62 | 7.5 | 5.5 | Upgrade
|
| Earnings From Continuing Operations | 402.57 | 283.89 | 20.5 | 71.6 | 11.73 | 75.19 | Upgrade
|
| Minority Interest in Earnings | -4.43 | -1.88 | -3.46 | 3.58 | 5.47 | 6.81 | Upgrade
|
| Net Income | 398.14 | 282 | 17.04 | 75.18 | 17.2 | 81.99 | Upgrade
|
| Net Income to Common | 398.14 | 282 | 17.04 | 75.18 | 17.2 | 81.99 | Upgrade
|
| Net Income Growth | 4290.80% | 1555.09% | -77.34% | 337.08% | -79.02% | -15.96% | Upgrade
|
| Shares Outstanding (Basic) | 92 | 92 | 92 | 92 | 92 | 92 | Upgrade
|
| Shares Outstanding (Diluted) | 92 | 92 | 92 | 92 | 92 | 92 | Upgrade
|
| EPS (Basic) | 4.33 | 3.06 | 0.19 | 0.82 | 0.19 | 0.89 | Upgrade
|
| EPS (Diluted) | 4.33 | 3.06 | 0.19 | 0.82 | 0.19 | 0.89 | Upgrade
|
| EPS Growth | 3545.57% | 1555.10% | -77.34% | 337.08% | -79.02% | -15.96% | Upgrade
|
| Free Cash Flow | 368.69 | 295.18 | -38.53 | -173.5 | -339.94 | -522.22 | Upgrade
|
| Free Cash Flow Per Share | 4.01 | 3.21 | -0.42 | -1.89 | -3.69 | -5.67 | Upgrade
|
| Dividend Per Share | 0.500 | 0.500 | - | - | - | - | Upgrade
|
| Gross Margin | 38.46% | 38.23% | 37.83% | 31.23% | 31.78% | 32.09% | Upgrade
|
| Operating Margin | 14.51% | 15.29% | 12.21% | 6.52% | 2.90% | 6.14% | Upgrade
|
| Profit Margin | 13.60% | 9.78% | 0.64% | 3.49% | 0.92% | 4.68% | Upgrade
|
| Free Cash Flow Margin | 12.60% | 10.24% | -1.45% | -8.06% | -18.15% | -29.83% | Upgrade
|
| EBITDA | 619.33 | 628.82 | 497.7 | 269.9 | 185.15 | 228.42 | Upgrade
|
| EBITDA Margin | 21.16% | 21.81% | 18.76% | 12.54% | 9.89% | 13.05% | Upgrade
|
| D&A For EBITDA | 194.49 | 187.88 | 173.73 | 129.56 | 130.91 | 121.01 | Upgrade
|
| EBIT | 424.84 | 440.93 | 323.97 | 140.34 | 54.24 | 107.41 | Upgrade
|
| EBIT Margin | 14.51% | 15.29% | 12.21% | 6.52% | 2.90% | 6.14% | Upgrade
|
| Effective Tax Rate | 5.70% | 8.47% | 89.27% | 11.84% | 39.00% | 6.82% | Upgrade
|
| Advertising Expenses | - | 16.39 | 9.74 | 7.59 | 7.13 | 3.78 | Upgrade
|
Updated Mar 2, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.